1. Home
  2. JBI vs NBTX Comparison

JBI vs NBTX Comparison

Compare JBI & NBTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Janus International Group Inc.

JBI

Janus International Group Inc.

HOLD

Current Price

$6.82

Market Cap

945.4M

Sector

Industrials

ML Signal

HOLD

Logo Nanobiotix S.A.

NBTX

Nanobiotix S.A.

HOLD

Current Price

$22.57

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
JBI
NBTX
Founded
2002
2003
Country
United States
France
Employees
N/A
N/A
Industry
Building Products
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
945.4M
1.0B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
JBI
NBTX
Price
$6.82
$22.57
Analyst Decision
Buy
Strong Buy
Analyst Count
4
1
Target Price
$10.13
$8.00
AVG Volume (30 Days)
2.2M
50.1K
Earning Date
11-06-2025
09-30-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.34
N/A
Revenue
$888,700,000.00
$11,930,711.00
Revenue This Year
N/A
N/A
Revenue Next Year
$1.58
$136.64
P/E Ratio
$20.29
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.73
$2.82
52 Week High
$10.80
$30.35

Technical Indicators

Market Signals
Indicator
JBI
NBTX
Relative Strength Index (RSI) 50.17 56.36
Support Level $5.96 $20.83
Resistance Level $7.03 $23.77
Average True Range (ATR) 0.28 0.83
MACD 0.22 0.16
Stochastic Oscillator 79.07 72.52

Price Performance

Historical Comparison
JBI
NBTX

About JBI Janus International Group Inc.

Janus International Group Inc is a manufacturer and supplier of turnkey solutions for self-storage, commercial, and industrial building Solutions. The company provides products that include roll-up and swing doors, hallway systems, relocatable storage MASS (Moveable Additional Storage Structures) units, and technologies for automating facility and door operation. It is operated through two geographic regions; Janus North America and Janus International. The Janus International segment is comprised of a subsidiary whose production and sales are largely in Europe and Australia. The Janus North America segment is comprised of all the other entities.

About NBTX Nanobiotix S.A.

Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.

Share on Social Networks: